REC — Recordati Industria Chimica E Farmaceutica SpA Balance Sheet
0.000.00%
Last trade - 00:00- €10.20bn
- €12.37bn
- €2.34bn
- 92
- 20
- 75
- 71
Annual balance sheet for Recordati Industria Chimica E Farmaceutica SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 188 | 245 | 285 | 222 | 322 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 314 | 350 | 424 | 542 | 622 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 773 | 850 | 1,174 | 1,202 | 1,491 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 133 | 131 | 159 | 179 | 207 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,712 | 2,816 | 3,999 | 4,208 | 5,134 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 578 | 626 | 924 | 1,003 | 929 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,436 | 1,435 | 2,453 | 2,522 | 3,258 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,276 | 1,382 | 1,546 | 1,686 | 1,877 |
| Total Liabilities & Shareholders' Equity | 2,712 | 2,816 | 3,999 | 4,208 | 5,134 |
| Total Common Shares Outstanding |